Literature DB >> 17170630

Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient.

Kirk M Chan-Tack1, Navneet Ahuja, Edward J Weinman, Ravinder K Wali, Anayochukwu Uche, Lisa A Greisman, Cinthia Drachenberg, Philip N Hawkins, Robert R Redfield.   

Abstract

Amyloidosis is an uncommon cause of renal disease in HIV-positive patients. Diagnosis is challenging, treatment options are limited, and prognosis remains poor. We discuss an HIV-positive patient with acute renal failure and nephrotic range proteinuria. The differential diagnosis included nephropathy due to trimethoprim/sulfamethoxazole, tenofovir, HIV, hepatitis C, heroin, or multifactorial causes. Serum and urine study findings were inconclusive. Rapid clinical deterioration ensued and a renal biopsy was performed. Pathologic examination revealed eosinophilic, amorphous material in the glomerular tufts that stained red-orange with Congo red stain. Immunohistochemical analysis confirmed amyloid A (AA) amyloidosis. AA amyloidosis occurs as a complication of chronic infection or chronic inflammatory disease. It has been reported in intravenous or subcutaneous drug abusers, some of whom were HIV-positive. This case underscores the importance of tissue diagnosis to determine the cause of renal disease in HIV-positive patients. Clinical diagnosis, based on CD4 count, viral load, and degree of proteinuria, may not predict the pathological diagnosis in HIV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170630     DOI: 10.1097/00000441-200612000-00012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Treatment of renal AA-Amyloidosis associated with human immunodeficiency virus infection: a case report.

Authors:  Janice Borg; Jesmar Buttigieg; Stephen Holwill; Charles Mallia Azzopardi
Journal:  CEN Case Rep       Date:  2020-09-05

Review 2.  The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era.

Authors:  Jiqing Xu; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-19       Impact factor: 4.147

3.  Renal AA-amyloidosis in intravenous drug users--a role for HIV-infection?

Authors:  Oliver Jung; Hans Stefan Haack; Maike Buettner; Christoph Betz; Christoph Stephan; Peter Gruetzmacher; Kerstin Amann; Markus Bickel
Journal:  BMC Nephrol       Date:  2012-11-21       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.